Suppr超能文献

肾盂和输尿管移行细胞癌中DNA倍体模式的预后意义:持续随访

The prognostic significance of DNA ploidy pattern in transitional cell cancer of the renal pelvis and ureter: continuing follow-up.

作者信息

Corrado F, Mannini D, Ferri C, Corrado G, Bertoni F, Bacchini P, Lieber M M, Song J M

机构信息

Divisione di Urologia I, Ospedale Policlinico S. Orsola-Malpighi, Bologna, Italia.

出版信息

Eur Urol. 1992;21 Suppl 1:48-50. doi: 10.1159/000474889.

Abstract

Among 190 patients operated on for transitional cell cancer of the renal pelvis and/or ureter from 1976 to 1990, 95 had their tumor studied by flow cytometry. Of these, the prognostic significance of the DNA ploidy pattern with respect to the standard pathologic features was assessed in a retrospective analysis, where survival information were updated to October 1991 and the mean follow-up of patients exceeded 5.5 years (longest follow-up: 15.5 years). Five and ten-year survival probabilities for the whole group were, respectively, 65.5 and 51%. Patients with a diploid tumor had significantly better survival rates than patients with tetraploid/aneuploid cancer (p less than 0.00001). The impact of the DNA ploidy on survival was confirmed by a multivariate analysis of prognostic factors, where only tumor grade (p less than 0.0001), tumor stage (p less than 0.0001), number of neoplastic foci (p = 0.022) and nuclear DNA pattern (p less than 0.068) had a significant influence on survival. In the group of patients with low-stage (pTa-pT1) and low-grade (G1-G2) transitional cell cancer of the upper urinary tract, the DNA analysis was unable to identify any subset of patients at higher risk for disease progression.

摘要

在1976年至1990年间接受肾盂和/或输尿管移行细胞癌手术的190例患者中,95例患者的肿瘤接受了流式细胞术研究。在这些患者中,通过回顾性分析评估了DNA倍体模式相对于标准病理特征的预后意义,其中生存信息更新至1991年10月,患者的平均随访时间超过5.5年(最长随访时间:15.5年)。整个组的5年和10年生存概率分别为65.5%和51%。二倍体肿瘤患者的生存率明显高于四倍体/非整倍体癌症患者(p<0.00001)。通过对预后因素的多因素分析证实了DNA倍体对生存的影响,其中只有肿瘤分级(p<0.0001)、肿瘤分期(p<0.0001)、肿瘤病灶数量(p = 0.022)和核DNA模式(p<0.068)对生存有显著影响。在上尿路低分期(pTa-pT1)和低分级(G1-G2)移行细胞癌患者组中,DNA分析无法识别出任何疾病进展风险较高的患者亚组。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验